Lexicon Pharmaceuticals
LXRX
#6785
Rank
โ‚น75.03 B
Marketcap
โ‚น168.63
Share price
0.57%
Change (1 day)
22.59%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -โ‚น5.65 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น41.46 Million. In 2025 the company made an earning of -โ‚น4.86 Billion, an increase over its 2024 earnings that were of -โ‚น19.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น5.65 Billion16.31%
2025 -โ‚น4.86 Billion-74.88%
2024 -โ‚น19.32 Billion13.15%
2023 -โ‚น17.07 Billion73.74%
2022 -โ‚น9.83 Billion16.16%
2021 -โ‚น8.46 Billion49.82%
2020 -โ‚น5.65 Billion-147.19%
2019 โ‚น11.96 B-203.42%
2018 -โ‚น11.57 Billion-15.31%
2017 -โ‚น13.66 Billion0.2%
2016 -โ‚น13.63 Billion2920.7%
2015 -โ‚น0.46 Billion-95.33%
2014 -โ‚น9.68 Billion-3.61%
2013 -โ‚น10.04 Billion-5.52%
2012 -โ‚น10.62 Billion-4.17%
2011 -โ‚น11.09 Billion15.5%
2010 -โ‚น9.6 Billion8.36%
2009 -โ‚น8.86 Billion-4.81%
2008 -โ‚น9.31 Billion28.79%
2007 -โ‚น7.23 Billion35.71%
2006 -โ‚น5.33 Billion52.91%
2005 -โ‚น3.49 Billion-23.89%
2004 -โ‚น4.58 Billion-24.19%
2003 -โ‚น6.04 Billion-0.48%
2002 -โ‚น6.07 Billion44.12%
2001 -โ‚น4.21 Billion23.01%
2000 -โ‚น3.42 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น735.90 B-12,595.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น111.77 B-1,998.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น497.79 B-8,552.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚น48.73 Billion 727.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น23.52 B-499.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น7.64 B-229.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚น2.24 Billion-61.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น14.36 B-343.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น1.6 Billion-72.97%๐Ÿ‡บ๐Ÿ‡ธ USA